The Optimizing Antibiotic Stewardship in California NICUs (OASCN) Collaborative was active from March 2021 – February 2023.
The Optimizing Antibiotic Stewardship in California NICUs (OASCN) Collaborative aimed to scale up dissemination of various nationally recommended interventions to improve antimicrobial stewardship among NICUs in California using a blended QI collaborative and ECHO™ (Extension for Community Healthcare Outcomes) tele-learning model. ECHO™ is an evidence-based, American Academy of Pediatrics-endorsed method of practice dissemination used globally that focuses on faculty-facilitated, case-based learning tailored to how clinicians are inclined to learn and build practice consensus. QI collaboratives, while similarly including faculty facilitation and peer-learning, focus on supporting continuous quality improvement efforts by site implementation teams. OASCN was supported by a grant from the Agency for Healthcare Research and Quality (AHRQ Grant# R18HS26168-01A1) to implement and evaluate the collaborative.
Why we care about this topic
We all would like to evolve our practice towards the safest and most appropriate use of antibiotics for our newborns. Unnecessary and/or inappropriate antibiotic use continues to be a problem in the NICU setting with the potential for harm to neonates. At the same time, professional associations, accreditors, and ongoing national initiatives highlight the increasing urgency of antimicrobial resistance and stewardship.
We designed this collaborative with partners at the RAND Corporation and The Lundquist Institute at Harbor-UCLA Medical Center in Los Angeles to include the latest in collaborative learning approaches. OASCN began with 31 California NICUs and hosted Learning Sessions open to all NICU clinical staff via Zoom every 2 weeks from early March 2021 through February 2022 and quarterly thereafter until February 2023. Other collaborative activities and supports included a Learning Points recap email after each biweekly session, a collaborative email listserv and filesharing site, and an online data submission and QI analytics portal. The primary goal of the OASCN Collaborative was to safely reduce antibiotic usage rate (AUR) for all infants at participating NICUs. Participating NICUs selected which gestational ages to focus their improvement efforts (e.g. preterm, late preterm, term babies).
Benefits of this collaborative included
- Participation in interactive, case-based learning sessions guided by a multidisciplinary faculty panel on NICU antibiotic prescribing
- Sharing experiences and lessons with NICUs across the state on optimizing antibiotic use
- Learning and applying principles of implementing quality improvement
- Reducing antibiotic utilization
The OASCN Resource Bundle is available here. We hope you find these resources valuable.
OASCN Faculty Panel, Learning Team, and Evaluation Team
The following team members comprised the OASCN Faculty Panel, Learning Team, and Evaluation Team in 2021-2023.
Alice Pong, MD, Rady Children’s
Bill Benitz, MD, Stanford University
Courtney Armstrong, MPH, RAND Corporation
Cynthia Gong, PharmD, PhD, USC
Henry Lee, MD, MS, CPQCC
Irineo Cabreros, PhD, RAND Corporation
Jack Kroger, MSc, RAND Corporation
Janine Bohnert, BS, CPQCC
Jason Sauberan, PharmD, Rady Children’s
Joseph Schulman, MD, MS, California Children’s Services (CCS)
Ken Zangwill, MD, The Lundquist Institute at Harbor-UCLA Medical Center
Kristen Schaffer, MPH, CPQCC
Kurlen Payton, MD, Cedars-Sinai Medical Center
Lillian Sie, MPH, CPQCC
Linda Lefrak, MSN, RN, California Department of Public Health
Megan Schuler, PhD, RAND Corporation
Michael Bolaris, MD, Harbor-UCLA Medical Center
Nabeel Qureshi, MPH, RAND Corporation
Peter Mendel, PhD, RAND Corporation
Victor Wong, MD, Kaiser Permanente
Related Publication: Blood culture procedures and practices in the neonatal intensive care unit: A survey of a large multicenter collaborative in California